دورية أكاديمية

Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان: Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
المؤلفون: Yamamoto, Chihiro, Minakata, Daisuke, Yokoyama, Daizo, Furuki, Shuka, Noguchi, Atsuto, Koyama, Shunsuke, Oyama, Takashi, Murahashi, Rui, Nakashima, Hirotomo, Ikeda, Takashi, Kawaguchi, Shin-ichiro, Hyodo, Kazuki, Toda, Yumiko, Ito, Shoko, Nagayama, Takashi, Umino, Kento, Morita, Kaoru, Ashizawa, Masahiro, Ueda, Masuzu, Hatano, Kaoru, Sato, Kazuya, Ohmine, Ken, Fujiwara, Shin-ichiro, Kanda, Yoshinobu
المساهمون: Takeda Pharmaceutical Company, Daiichi-Sankyo
المصدر: Transplantation and Cellular Therapy ; volume 30, issue 1, page 118.e1-118.e15 ; ISSN 2666-6367
بيانات النشر: Elsevier BV
سنة النشر: 2024
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Transplantation, Cell Biology, Hematology, Molecular Medicine, Immunology and Allergy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jtct.2023.10.001
الإتاحة: https://doi.org/10.1016/j.jtct.2023.10.001Test
https://api.elsevier.com/content/article/PII:S2666636723015816?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666636723015816?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.2DCF1024
قاعدة البيانات: BASE